​

U.S. Patent No. 8,911,727, entitled “Monoclonal Antibody Human Non-small Cell Lung Carcinoma and Use Thereof”

U.S. Patent No. 10,444,237, entitled “Anti-Pancreatic Cancer Monoclonal Antibody and Use Thereof”

​

AUS Patent No. 2012331968 B2, entitled "Monoclonal antibody against human non-small-cell lung carcinoma and use thereof"

​

CN Patent No. 106399536A, Entitled "Body Fluid Circulation DNA Quantitative Determination Method and Kit"

​

CN Patent NO. CN105462935A, entitled "Monoclonal Antibody Resisting Ovarian Cancer Application Thereof"

​

CN Patent No. CN103439509B, entitled "Application of Specific Circulating Non-small Cell Lung Cancer Cell Marker"

​

CN Patent No. CN 103602678A, entitled "Non-small Cell Lung Cancer Prognosis Detection Composition and Applications Thereof"

​

CN Patent No. CN102944681A, entitled "Application of Non-Small Cell Lung Cancer Pleural effusion Tumor Marker"

​

CN Patent No. WO2013063876A1, entitled "Double Antibody Sandwiched ELISA Kit For Detecting Non-small Cell Lung cancer and Applications Thereof"

​

CN Patent No. CN105462935B, entitled "China Ovarian Cancer Resistance Monoclonal Antibody and Its Application"

​

WIPO Patent No. WO2013063874A1, entitled "Monoclonal Antibody Against Human Non-small Cell Lung Carcinoma and Use thereof"

​

​